According to research, lorlatinib is both safe and effective for patients with high-risk ALK-driven relapsed/refractory neuroblastoma.

Published Date: 07 Apr 2023

Early nerve cells give rise to the aggressive pediatric cancer known as neuroblastoma, which frequently manifests as a solid tumor in the chest or abdomen. The.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Researchers find distinct cell receptors with the potential for new treatments.

2.

Breast cancer patients' arms swell less after an effective lymph node transfer.

3.

Telehealth in the pandemic era resulted in fewer therapy interruptions.

4.

Too Many Chest CTs for Incidental Lung Nodules?

5.

Global warming could be driving up women's cancer risk, find researchers


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot